Dr. Thomas E. Gundersen is CEO and co-founder of Vitas and obtained his Master in organic analytical chemistry at the Department of Chemistry, University of Oslo in 1995, and later his Ph.D. (Dr. Philos) from the Department of Nutrition, Medical Faculty, University of Oslo. He has published a number of papers in the field of chromatographic determination of lipids, phytochemicals, vitamins and antioxidants.
Type II diabetes - the silent pandemic
Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. It is a major health problem worldwide and has been called a "silent pandemic" due to its widespread prevalence and impact on public health. Vitas offers the analysis of HbA1c from liquid whole blood, red blood cells, and dried blood spots (DBS). We provide high throughput capabilities compatible with large scale population screening. In addition we offer a set of additional assays to be used in clinical studies and diabetes related research. These include Satiety hormones like PYY, CCK, Ghrelin, Leptin and GLP-1. Also C-peptide and lipids like triacylglycerols (TAG).
The Carotenoids - Natures Rainbow
Carotenoids, vibrant pigments found in plants and fruits, possess remarkable biological functions and play a vital role in nature, human health, and food manufacturing. This article explores their types, functions, chemistry, health benefits, and their significance in food coloring. Carotenoids act as antioxidants, attract pollinators, and provide visual signals in plants. Animals obtain carotenoids from their diet, influencing coloration and providing biological functions. Carotenoids are widely used in the food industry as natural colorants.
Test for Covid-19 on DBS
With support from the Norwegian Research Council, Vitas has developed and validated an IgG serology test for covid-19 in dried blood spots (DBS).
Test for covid-19 antibodies on dried blood spots (DBS)
One newly discovered mutant of the SARS-CoV-2 virus is omicron. The scientific community is working intensely to clarify if the available vaccines protect against omicron, and if the rapid test antigen for the spike 1 protein recognizes the virus and with what sensitivity. Antibodies produced due to omicron infection may also be different from other mutations and undetectable with IgG assays based on the original spike 1 protein.
One million DBS samples received, analyzed and reported
As of December 16, 2021 we have reached an important and noteworthy milestone. One million dried blood spot (DBS) samples have been sent from customers all around the world for analysis of different biomarkers. We currently receive 350 000 DBS samples annually with typical 25 % increase per year, and the rate is increasing from year to year as new customers and new assays are made available.